Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Biogen Idec
Homme Max 99 ans
Biogen Idec Research Ltd
MAJ Il y a 4 ans
A clinical study involving children up to age of 12 years with severe hemophilia A, to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it works to prevent and stop bleeds
The primary objective of the study is to evaluate safety of rFVIIIFc in previously treated pediatric subjects with hemophilia A.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 4 ans
Long-Term Extension Study of BIIB023 in Subjects with Lupus Nephritis
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB023 in subjects with LN.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec
MAJ Il y a 4 ans
A safety study for patients with Relapsing Forms of Multiple Sclerosis who participated STRATA. Een veiligheidsstudie voor patiënten met recidiverende vormen van Multiple Sclerose, die deel hebben genomen aan de STRATA studie
The primary objective for this study is long-term safety (incidence and pattern of SAEs) in patients receiving natalizumab.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Biogen Idec Research Ltd
MAJ Il y a 4 ans
A clinical study involving people with severe haemophilia B to look at how safe an experimental replacement factor IX protein (known as rFIXFc) is to take and how well it works to prevent and stop bleeds
The primary objective of the study is to evaluate the long-term safety of rFIXFc in subjects with hemophilia B.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Italia S.r.l
MAJ Il y a 4 ans
Study to evaluate the efficacy of cetirizine in the treatment of Flu-like syndrome (FLS) in patients with multiple sclerosis treated with interferoneβ
To evaluate the effectiveness of the administration of cetirizine 10 mg on the improvement of the symptoms of FLS. The primary objective of the study was the mean change in subjective seriousness of t...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec Research Limited
MAJ Il y a 4 ans
Study to Evaluate the Long Term Safety, Tolerability, and Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
The primary objective of the study is to evaluate the long term safety and tolerability of BIIB074 in subjects with neuropathic PLSR.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Biogen Idec International GmbH
MAJ Il y a 4 ans
A prospective, open label, non-randomised, clinical trial to determine if natalizumab (Tysabri) improves ambulatory measures in relapsing remitting multiple sclerosis (RRMS) patients
To evaluate the evolution of walking capacity as measured by T100T, T25FW, MWD and EDSS during the first year of therapy with natalizumab
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
4
5
6
7
8
9